# FDA Approves Generic Drug Application for Sun Pharmaceutical Industries Sun Pharmaceutical Industries Inc. received FDA approval for an abbreviated new drug application (ANDA090659) on April 10, 2009, expanding the company's generic drug portfolio and positioning it to capture market share in an additional therapeutic segment. The approval strengthens Sun Pharma's competitive position in the generic pharmaceutical market and is expected to contribute to revenue growth through increased market penetration.